Skip to main content
Susan Parsons, MD, Pediatric Hematology & Oncology, Boston, MA, Tufts Medical Center

SusanKParsonsMD

Pediatric Hematology & Oncology • Boston, MA

Pediatric Hematologic Oncology

Professor, Medicine, Tufts Medical Center

Join to view full profile

Dr. Parsons is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Parsons' full profile

Already have an account?

Education & Training

  • Children's Hospital/Boston Medical Center
    Children's Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1989 - 1991
  • Children's Hospital/Boston Medical Center
    Children's Hospital/Boston Medical CenterResidency, Pediatrics, 1986 - 1989
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1986

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1989 - 2024

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Late Effects Are Important Considerations in Initial Hodgkin Lymphoma Treatment Decision-Making According to Survivors
    Susan K Parsons, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Treatment with Full Chemotherapy Regimens in Older Adults with Hodgkin Lymphoma Improves 3-Year Overall Survival, but Less Than Half Receive Full Regimens
    Susan K Parsons, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • The Development and Validation of an Electronic Health Record (EHR)-Based Algorithm for Identifying Treatment Failure in Newly Diagnosed Hodgkin Lymphoma (HL) Treated ... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Significantly Improved Long Term Health Related Quality of Life (HRQL) and Neurocognition Following Familial Haploidentical Stem Cell Transplantation (HISCT) Utilizing... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplan... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Authored Content

  • The Creation of a Comprehensive Adolescent and Young Adult Cancer Survivorship Program: “Lost in Transition” No MoreJuly 2020
  • The Creation of a Comprehensive Adolescent and Young Adult Cancer Survivorship Program: “Lost in Transition” No MoreJuly 2020

Press Mentions

  • Investigators Develop Model to Predict Overall Survival in Adults Diagnosed with Advanced Stage Hodgkin Lymphoma
    Investigators Develop Model to Predict Overall Survival in Adults Diagnosed with Advanced Stage Hodgkin LymphomaDecember 9th, 2022
  • Building an International Consortium to Enhance Decision Making in Hodgkin Lymphoma
    Building an International Consortium to Enhance Decision Making in Hodgkin LymphomaMay 29th, 2020
  • Susan Parsons, MD, on Inconsistent Use of PET-Adapted Approaches in Hodgkin Lymphoma
    Susan Parsons, MD, on Inconsistent Use of PET-Adapted Approaches in Hodgkin LymphomaSeptember 17th, 2023

Grant Support

  • Innovative Statistical Methods For The Integration Of Functional And Clinical OutNational Cancer Institute2010–2011
  • Hsct-Chess To Enhance Hematopoietic Transplant RecoveryNational Cancer Institute2006–2010

Hospital Affiliations

Dr. Susan Parsons, Dr. Susan Parsons, MD, Dr. S Parsons, Dr. Susan K Parsons